Remarkably, MCL1 overexpression is associated with poor prognostic outcome in multiple myeloma, breast cancer, relapsing acute myeloid leukaemia and acute lymphocytic leukaemia, so the mechanisms that increase MCL1 levels are of paramount importance. Here, MCL1 is linked to acute lymphoblastic leukemia.